Enlivex Terminates $400M Rain Foundation Private Placement
ENLV is trading near its 52-week low of $0.64 (9.5% above the low) on elevated volume (2.4× avg).
Summary
Enlivex terminated its $400M private placement with the Rain Foundation, canceling the planned issuance of 66.7M shares for RAIN tokens. The company will not seek shareholder approval for the deal.
Key Events · Financing and Capital Events · ENLV
-
$400M Private Placement Terminated
The securities purchase agreement with the Rain Foundation has been terminated, canceling the planned sale of 66,666,667 ordinary shares for RAIN tokens.
-
No Shareholder Vote on Placement
Shareholder approval will not be sought for the private placement, removing the need for a vote on the transaction.
-
Capital Raise Removed
The termination eliminates a $400M capital infusion that was priced at a premium to market, leaving the company without this funding source.
-
Prior Disclosure Context
The agreement was originally announced on July 28, 2026, and was subject to shareholder approval; this filing reports its termination effective September 22, 2026.
Analysis · ENLV · Life Sciences
The termination of the $400 million private placement with the Rain Foundation, first announced on July 28, 2026, removes a major source of anticipated capital and eliminates the associated dilution. The deal would have issued 66,666,667 ordinary shares in exchange for RAIN tokens, subject to shareholder approval. With the agreement now terminated, questions arise about the company's funding runway and its relationship with the Rain Foundation. The company will not seek shareholder approval for the placement.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENLV was trading at $0.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $12.1M. The 52-week trading range was $0.64 to $27.15. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.